No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

byKathleen Lau

October 21, 2021

in StudyGraphics

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

RelatedReports

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026

Hematology

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

September 13, 2026

Prescription of antibiotics for acute respiratory infections increasing

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Fulvestrant-palbociclib and letrozole-palbociclib are equally effective for HR⁺ advanced breast cancer

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

Participation in sports and exercise linked to lower opioid use

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

Borderline-low hemoglobin levels linked to increased mortality

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

RelatedReports

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

Borderline-low hemoglobin levels linked to increased mortality

N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

#VisualAbstract: Dose-escalated concurrent chemoradiotherapy does not improve survival in locally advanced esophageal cancer

Transgender veterans may be more likely to use amphetamine, cocaine, and cannabis than cisgender veterans

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract Venetoclax with dose-adjusted EPOCH-R may be a promising combination therapy for aggressive B-cell lymphoma

RELATED REPORTS

Treatment of patent ductus arteriosus in very low birth weight infants varies between hospitals

Male sex and older age are independently associated with treatment failure after antibiotic treatment of community-acquired pneumonia

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits